<DOC>
	<DOCNO>NCT00080210</DOCNO>
	<brief_summary>This randomize , open-label , multicenter , parallel-groups study multiple intravenous dos Puricase , administer intravenously , 40 patient symptomatic gout . Subjects must wash uric acid-lowering agent one week dose , must refrain use agent throughout study .</brief_summary>
	<brief_title>A Study Persons With Gout Who Do Not Respond Are Allergic Conventional Therapy</brief_title>
	<detailed_description />
	<mesh_term>Gout</mesh_term>
	<mesh_term>Uric Acid</mesh_term>
	<criteria>Subjects include study : Outpatients either gender , age 18 old Diagnosed symptomatic gout refractory conventional therapy unable tolerate conventional therapy ( example : one tophus and/or experience gout flare within previous 6 month and/or chronic , gouty arthritis ) Hyperuricemic : screening serum uric acid must &gt; =8 mg/dL . The patient must willing able give inform consent adhere visit/protocol schedule ( Consent must give study procedure perform ) Women childbearing potential must negative serum pregnancy test must use approved birth control method participation protocol . Such method include oral , injectable , implantable contraceptive ; IUDs barrier contraceptive combination spermicide Subjects exclude follow apply : Unstable coronary artery disease uncontrolled hypertension History end stage renal disease require dialysis History liver disease , define baseline serum transaminase elevation &gt; 3X upper limit normal absence know cause Organ transplant recipient require immunosuppressive therapy Concurrent use prednisone dose &gt; 10 mg qd ( equivalent ) within one week dose Concurrent use uric acidlowering agent Prior treatment Puricase® recombinant uricase An acute gout flare within one week prior first treatment Puricase® ( exclusive chronic synovitis/arthritis ) require use medication violate protocol glucose6phosphate dehydrogenase deficiency A history anaphylactic reaction recombinant protein porcine derivative Lactation Has take investigational drug within 4 week prior study drug administration plan take investigational agent study Known allergy urate oxidase PEGylated product Has medical psychological condition , opinion investigator , might create undue risk patient interfere patient 's ability comply protocol requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>elevate uric acid</keyword>
	<keyword>Elevated serum uric acid level</keyword>
	<keyword>Symptomatic gout</keyword>
</DOC>